世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

North America Healthcare Cold Chain Logistics Market Report by Product (Biopharmaceuticals, Vaccines, Clinical Trials), Segment (Transportation, Packaging, Instrumentation), and Country 2025-2033

North America Healthcare Cold Chain Logistics Market Report by Product (Biopharmaceuticals, Vaccines, Clinical Trials), Segment (Transportation, Packaging, Instrumentation), and Country 2025-2033


The North America healthcare cold chain logistics market size reached USD 7.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.1 Billion by 2033, exhibiting a growth... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
IMARC Services Private Limited.
アイマークサービス
2025年6月2日 US$2,999
シングルユーザーライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
3-5営業日以内 121 英語

 

Summary

The North America healthcare cold chain logistics market size reached USD 7.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.1 Billion by 2033, exhibiting a growth rate (CAGR) of 3.9% during 2025-2033. The increasing cellular therapies and biomarker testing, escalating need to reduce wastage and financial losses, and surging demand for vaccines to treat numerous diseases among individuals represent some of the key factors driving the market.

Healthcare cold chain logistics refers to the specialized handling, transportation, and storage of temperature-sensitive pharmaceuticals, vaccines, and biologics to ensure their integrity and efficacy. It involves the use of temperature-controlled environments and equipment throughout the supply chain to maintain the required temperature range and prevent any deviations that could compromise the quality of healthcare products. Cold chain logistics is crucial for preserving the potency and safety of temperature-sensitive healthcare products, as they can be sensitive to temperature variations. It encompasses various activities, including packaging, transportation, monitoring, and quality control, to ensure that these products are maintained within the required temperature conditions from manufacturing to end-use, safeguarding patient health and medication effectiveness.

The increasing demand for temperature-sensitive pharmaceuticals, biologics, and vaccines, coupled with advancements in medical research and biotechnology, has contributed to the uptake of healthcare cold chain logistics in North America. These temperature-sensitive healthcare products require specialized handling and transportation to maintain their efficacy and safety. Moreover, the implementation of stringent regulatory requirements and quality standards imposed by regulatory bodies, such as the U.S. Food and Drug Administration (FDA), have reinforced the importance of maintaining proper temperature controls throughout the supply chain. This, in turn, has accelerated the product adoption rate. Additionally, the increasing complexity and globalization of the pharmaceutical and healthcare supply chains have led to a greater emphasis on end-to-end visibility and traceability. Furthermore, the rise of personalized medicine and biopharmaceuticals has augmented the demand for cold chain logistics, propelling the market growth.

North America Healthcare Cold Chain Logistics Market Trends/Drivers:
Increase in Demand for Biologics and Specialty Pharmaceuticals

The increasing demand for biologics and specialty pharmaceuticals will stimulate the growth of the market in North America. Biologics, including vaccines, gene therapies, and monoclonal antibodies, are complex and delicate products that often require specific temperature conditions to maintain their efficacy. Similarly, specialty pharmaceuticals, such as oncology drugs and immunosuppressants, are often temperature-sensitive and require precise handling throughout the supply chain. The growing adoption of personalized medicine, advancements in biotechnology, and the development of innovative therapies are driving the demand for these specialized pharmaceutical products. As a result, there is an increased need for reliable cold chain logistics services that can ensure the integrity and potency of these temperature-sensitive products.

Rise in Need for Regulatory Compliance

Stringent regulatory compliance is another key driver for the market. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and Health Canada, have established stringent guidelines and regulations to ensure the safety, quality, and efficacy of pharmaceuticals and healthcare products. These regulations mandate proper temperature control and traceability throughout the supply chain to prevent the degradation or compromise of temperature-sensitive products. Adhering to these regulatory requirements is crucial for pharmaceutical manufacturers, distributors, and healthcare providers to maintain compliance and ensure patient safety. To meet these regulations, organizations often rely on specialized cold chain logistics providers that have the expertise, infrastructure, and capabilities to maintain strict temperature controls, implement temperature monitoring systems, and provide real-time visibility and traceability.

North America Healthcare Cold Chain Logistics Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America healthcare cold chain logistics market report, along with forecasts at the regional and country levels from 2025-2033. Our report has categorized the market based on product and segment.

Breakup by Product:

? Biopharmaceuticals
? Vaccines
? Clinical Trials

Vaccines represents the most popular product

The report has provided a detailed breakup and analysis of the market based on the product. This includes biopharmaceuticals, vaccines, and clinical trials. According to the report, vaccines represented the largest segment.

Vaccines serve as the dominating product in the market due to several key factors. Moreover, the rising importance of vaccines in preventing and controlling infectious diseases has augmented the product demand. Additionally, vaccines play a vital role in public health by safeguarding individuals and communities from various diseases. In line with this, the rising need for timely and reliable distribution of vaccines necessitates a robust cold chain logistics infrastructure to maintain the required temperature conditions and ensure vaccine efficacy is propelling the segment growth. Furthermore, regulatory requirements and stringent quality standards set by regulatory bodies like the U.S. Food and Drug Administration (FDA) demand strict adherence to cold chain protocols. Compliance with these regulations ensures that vaccines maintain their potency and safety throughout the distribution process.

Breakup by Segment:

? Transportation
? Packaging
? Instrumentation

Transportation accounts for the majority of the market share

A detailed breakup and analysis of the market based on the segment has also been provided in the report. This includes transportation, packaging, and instrumentation. According to the report, transportation accounted for the largest market share.

Transportation serves as the dominating segment in the market due to the geographical vastness of the North America region necessitates extensive transportation networks that ensure timely and efficient delivery of temperature-sensitive healthcare products is propelling the segment growth. Besides this, the transportation segment plays a critical role in connecting various nodes of the cold chain, including manufacturing facilities, cold storage centers, healthcare facilities, and distribution points. Furthermore, the increasing demand for healthcare products, particularly temperature-sensitive pharmaceuticals, and biologics, has augmented the need for reliable transportation services. These products require specialized handling and strict temperature control during transit to maintain their efficacy and safety. The transportation segment must ensure seamless and continuous cold chain operations to preserve the integrity of these products throughout the supply chain.

Breakup by Country:

? United States
? Canada
? Mexico

United States hold the largest share in the market

The report has also provided a comprehensive analysis of all the major regional markets, which includes United States, Canada, and Mexico. According to the report, United States was the largest market for healthcare cold chain logistics in North America.

Some of the factors driving the market included the growing prevalence of lifestyle diseases among individuals, increasing cross-border trades, and the rising need to reduce wastage of medical products. The size and complexity of the healthcare industry in the U.S. contribute to its dominance. The country has a large population, high healthcare expenditure, and advanced healthcare infrastructure, which has augmented demand for temperature-sensitive pharmaceuticals, vaccines, and biologics. This demand drives the need for robust cold chain logistics services to ensure the safe and efficient delivery of these products.

Moreover, the presence of major pharmaceutical manufacturers and biotech companies in the United States is positively influencing the market growth. The country is also home to numerous leading healthcare and pharmaceutical companies that require reliable cold chain logistics for their products. These companies often have extensive distribution networks, making the U.S. a crucial hub for cold chain logistics operations. Furthermore, regulatory compliance and quality standards set by organizations like the U.S. Food and Drug Administration (FDA) is contributing to the market growth.

Competitive Landscape:
The key players in the market have made several innovations and advancements to meet the evolving demands of consumers and businesses. Market players have introduced advanced temperature monitoring systems that utilize sensors, data loggers, and real-time monitoring technology to track and monitor temperature conditions during transportation and storage. In addition, key players are developing specialized thermal packaging, insulated containers, and phase-change materials to maintain consistent temperature control and protect products from external temperature fluctuations. These packaging solutions help ensure the stability and quality of healthcare products throughout the cold chain. Additionally, the rising number of strategic collaborations and partnerships between logistics providers, pharmaceutical manufacturers, and regulatory bodies to streamline cold chain processes and ensure compliance with regulatory requirements is supporting the market growth.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided.

Key Questions Answered in This Report
1.What was the size of the North America healthcare cold chain logistics market in 2024?
2.What is the expected growth rate of the North America healthcare cold chain logistics market during 2025-2033?
3.What are the key factors driving the North America healthcare cold chain logistics market?
4.What has been the impact of COVID-19 on the North America healthcare cold chain logistics market?
5.What is the breakup of the North America healthcare cold chain logistics market based on the product?
6.What is the breakup of the North America healthcare cold chain logistics market based on the segment?
7.What are the key regions in the North America healthcare cold chain logistics market?


ページTOPに戻る


Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Healthcare Cold Chain Logistics Market
5.1 Market Performance
5.2 Market Breakup by Product
5.3 Market Breakup by Segment
5.4 Market Breakup by Region
5.5 Market Forecast
6 North America Healthcare Cold Chain Logistics Market
6.1 Market Performance
6.2 Impact of COVID-19
6.3 Market Forecast
7 North America Healthcare Cold Chain Logistics Market: Breakup by Product
7.1 Biopharmaceuticals
7.2 Vaccines
7.3 Clinical Trials
8 North America Healthcare Cold Chain Logistics Market: Breakup by Segment
8.1 Transportation
8.2 Packaging
8.3 Instrumentation
9 North America Healthcare Cold Chain Logistics Market: Breakup by Country
9.1 United States
9.1.1 Historical Market Trends
9.1.2 Market Breakup by Product
9.1.3 Market Breakup by Segment
9.1.4 Market Forecast
9.2 Canada
9.2.1 Historical Market Trends
9.2.2 Market Breakup by Product
9.2.3 Market Breakup by Segment
9.2.4 Market Forecast
9.3 Mexico
9.3.1 Historical Market Trends
9.3.2 Market Breakup by Product
9.3.3 Market Breakup by Segment
9.3.4 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
11.1 Overview
11.2 Drug Production Facility
11.3 Refrigerated Warehouse
11.4 Transport (Air/Sea/Road/Rail)
11.5 Distribution Centres
11.6 Transport (Road)
11.7 End-Users
12 Porter’s Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Rivalry
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players

ページTOPに戻る



List of Tables/Graphs

List of Figures

Figure 1: North America: Healthcare Cold Chain Logistics Market: Major Drivers and Challenges
Figure 2: Global: Healthcare Cold Chain Logistics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Healthcare Cold Chain Logistics Market: Breakup by Product (in %), 2024
Figure 4: Global: Healthcare Cold Chain Logistics Market: Breakup by Segment (in %), 2024
Figure 5: Global: Healthcare Cold Chain Logistics Market: Breakup by Region (in %), 2024
Figure 6: Global: Healthcare Cold Chain Logistics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 7: North America: Healthcare Cold Chain Logistics Market: Sales Value (in Billion USD), 2019-2024
Figure 8: North America: Healthcare Cold Chain Logistics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: North America: Healthcare Cold Chain Logistics Market: Breakup by Product (in %), 2024
Figure 10: North America: Healthcare Cold Chain Logistics (Biopharmaceuticals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: North America: Healthcare Cold Chain Logistics (Biopharmaceuticals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: North America: Healthcare Cold Chain Logistics (Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: North America: Healthcare Cold Chain Logistics (Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: North America: Healthcare Cold Chain Logistics (Clinical Trials) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: North America: Healthcare Cold Chain Logistics (Clinical Trials) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: North America: Healthcare Cold Chain Logistics Market: Breakup by Segment (in %), 2024
Figure 17: North America: Healthcare Cold Chain Logistics (Transportation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: North America: Healthcare Cold Chain Logistics (Transportation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: North America: Healthcare Cold Chain Logistics (Packaging) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: North America: Healthcare Cold Chain Logistics (Packaging) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: North America: Healthcare Cold Chain Logistics (Instrumentation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: North America: Healthcare Cold Chain Logistics (Instrumentation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: North America: Healthcare Cold Chain Logistics Market: Breakup by Country (in %), 2024
Figure 24: United States: Healthcare Cold Chain Logistics Market: Sales Value (in Million USD), 2019-2024
Figure 25: United States: Healthcare Cold Chain Logistics Market: Breakup by Product (in %), 2024
Figure 26: United States: Healthcare Cold Chain Logistics Market: Breakup by Segment (in %), 2024
Figure 27: United States: Healthcare Cold Chain Logistics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Canada: Healthcare Cold Chain Logistics Market: Sales Value (in Million USD), 2019-2024
Figure 29: Canada: Healthcare Cold Chain Logistics Market: Breakup by Product (in %), 2024
Figure 30: Canada: Healthcare Cold Chain Logistics Market: Breakup by Segment (in %), 2024
Figure 31: Canada: Healthcare Cold Chain Logistics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Mexico: Healthcare Cold Chain Logistics Market: Sales Value (in Million USD), 2019-2024
Figure 33: Mexico: Healthcare Cold Chain Logistics Market: Breakup by Product (in %), 2024
Figure 34: Mexico: Healthcare Cold Chain Logistics Market: Breakup by Segment (in %), 2024
Figure 35: Mexico: Healthcare Cold Chain Logistics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: North America: Healthcare Cold Chain Logistics Industry: SWOT Analysis
Figure 37: North America: Healthcare Cold Chain Logistics Industry: Value Chain Analysis
Figure 38: North America: Healthcare Cold Chain Logistics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: North America: Healthcare Cold Chain Logistics Market: Key Industry Highlights, 2024 and 2033
Table 2: North America: Healthcare Cold Chain Logistics Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: North America: Healthcare Cold Chain Logistics Market Forecast: Breakup by Segment (in Million USD), 2025-2033
Table 4: North America: Healthcare Cold Chain Logistics Market Forecast: Breakup by Country (in Million USD), 2025-2033
Table 5: North America: Healthcare Cold Chain Logistics Market: Competitive Structure
Table 6: North America: Healthcare Cold Chain Logistics Market: Key Players

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(運輸)の最新刊レポート

IMARC Services Private Limited.社の 交通・ロジスティクス分野 での最新刊レポート

本レポートと同じKEY WORD(healthcare)の最新刊レポート


よくあるご質問


IMARC Services Private Limited.社はどのような調査会社ですか?


インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2025/11/11 10:26

155.36 円

179.79 円

207.28 円

ページTOPに戻る